Skip to main content
. 2020 Nov 11;60(5):2206–2216. doi: 10.1093/rheumatology/keaa544

Table 4.

Multivariable regression analyses characteristics associated with antidepressant or anticonvulsant prescription

Amitriptyline
Nortriptyline
Duloxetine
Gabapentin
Pregabalin
n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI)
Age category
30–39 86 (3.3) 1 13 (0.5) 1 26 (1.0) 1 15 (0.6) 1 67 (2.5) 1
40–49 685 (5.7) 1.69 (1.34, 2.12) 107 (0.9) 1.73 (0.97, 3.07) 126 (1.0) 1.00 (0.65, 1.52) 125 (1.0) 1.70 (0.99, 2.91) 429 (3.6) 1.34 (1.03, 1.74)
50–59 1863 (5.7) 1.62 (1.30, 2.03) 275 (0.8 1.59(0.91, 2.78) 301 (0.9) 0.83 (0.55, 1.24) 402 (1.2) 1.90 (1.13, 3.19) 1234 (3.8) 1.37 (1.06, 1.76)
60–69 2494 (5.1) 1.50 (1.20, 1.87) 462 (0.9) 1.86 (1.07, 3.24) 300 (0.6) 0.56 (0.37, 0.84) 675 (1.4) 2.10 (1.26, 3.51) 1905 (3.9) 1.46 (1.14, 1.86)
70–79 2361 (5.8) 1.63 (1.31, 2.03) 549 (1.3) 2.56 (1.47, 4.46) 270 (0.7) 0.57 (0.37, 0.85) 590 (1.4) 2.06 (1.23, 3.46) 1794 (4.4) 1.59 (1.24, 2.04)
80–89 1248 (5.3) 1.49 (1.19, 1.87) 365 (1.5) 2.98 (1.71, 5.21) 133 (0.6) 0.49 (0.32, 0.74) 295 (1.2) 1.79 (1.06, 3.02) 868 (3.7) 1.36 (1.05, 1.75)
> 90 126 (3.6) 1.05 (0.80, 1.40) 39 (1.0) 2.23 (1.18, 4.20) 9 (0.2) 0.72 (0.11, 0.50) 20 (0.5) 0.86 (0.78, 0.95) 85 (2.3) 0.98 (0.71, 1.36)
Gender
Female 7237 (6.3) 1 1371 (1.3) 1 862 (0.8) 1 1495 (1.4) 1 4570 (4.3) 1
Male 2202 (3.6) 0.62 (0.59, 0.65) 439 (0.8) 0.69 (0.63, 0.76) 303 (0.5) 0.72 (0.63, 0.82) 627 (1.1) 0.86 (0.78, 0.95) 1812 (3.2) 0.84 (0.79, 0.89)
Joint affected
Spine 1138 (6.2) 1 207 (1.2) 1 131 (0.8) 1 196 (1.1) 1 739 (4.3) 1
Hip 1256 (4.2) 0.70 (0.64, 0.76) 277 (1.0) 0.82 (0.78, 0.98) 166 (0.6) 0.91 (0.73, 1.15) 348 (1.3) 1.14 (0.96, 1.37) 868 (3.1) 0.76 (0.69, 0.84)
Knee 2043 (4.3) 0.70 (0.65, 0.74) 387 (0.9) 0.72 (0.61, 0.85) 230 (0.5) 0.75 (0.60, 0.93) 543 (1.2) 1.09 (0.93, 1.29) 1363 (3.0) 0.73 (0.67, 0.80)
Other peripheral joints 1957 (4.8) 0.73 (0.67, 0.79) 362 (1.0) 0.81 (0.69, 0.97) 250 (0.7) 0.84 (0.68, 1.04) 305 (0.8) 0.71 (0.60, 0.84) 1238 (3.3) 0.76 (0.69, 0.83)
Two or more joints 3045 (7.9) 1.04 (0.96, 1.11) 577 (1.6) 1.00 (0.85, 1.18) 388 (1.1) 1.34 (1.09, 1.64) 730 (2.0) 1.48 (1.26, 1.74) 2174 (6.0) 1.14 (1.04, 1.24)
MSD
No MSD 1373 (2.3) 1 322 (0.6) 1 198 (0.3) 1 352 (0.6) 1 802 (1.4) 1
Upper extremity 240 (3.0) 1.28 (1.11, 1.48) 60 (0.8) 1.44 (1.09, 1.90) 32 (0.4) 1.17 (0.80, 1.70) 66 (0.9) 1.43 (1.10, 1.86) 190 (2.5) 1.79 (1.53, 2.10)
Lower extremity 718 (4.0) 1.78 (1.62, 1.95) 135 (0.8) 1.42 (1.16, 1.74) 73 (0.4) 1.23 (0.94, 1.61) 200 (1.2) 1.87 (1.57, 2.22) 456 (2.7) 1.93 (1.72, 2.17)
Neck/back 690 (5.5) 2.43 (2.21, 2.68) 157 (1.3) 2.39 (1.98, 2.90) 90 (0.8) 2.12 (1.65, 2.72) 154 (1.3) 2.12 (1.75, 2.57) 519 (4.5) 3.19 (2.85, 3.65)
Other MSD 485 (4.2) 1.76 (1.58, 1.96) 105 (1.0) 1.72 (1.38, 2.15) 49 (0.5) 1.23 (0.90, 1.69) 110 (1.0) 1.63 (1.31, 2.02) 278 (2.6) 1.81 (1.57, 2.07)
≥2 MSD 5933 (9.1) 3.89 (3.65, 4.14) 1031 (1.7) 2.97 (2.62, 3.38) 723 (1.2) 3.07 (2.61, 3.60) 1240 (2.1) 3.15 (2.79, 3.56) 4137 (6.9) 4.82 (4.46, 5.21)

Values in bold are statistically significant (P< 0.05). The multivariable regression analyses were adjusted for age, gender, joint affected and musculoskeletal disorders. MSD: musculoskeletal disorders.